Essential fatty acid depletion in children with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 5, 2005, Pages 573-577

  Socha, Piotr ^a   Ryzko, Józef ^a   Koletzko, Berthold ^b   Celinska Cedro, Danuta ^a   Woynarowski, Marek ^a   Czubkowski, Piotr ^a   Socha, Jerzy ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Arachidonic acid; Crohn's disease; Inflammation; Leucotrienes; Polyunsaturated fatty acids; Ulcerative colitis

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; HEMOGLOBIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SEROMUCOID; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHILD NUTRITION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; ESSENTIAL FATTY ACID DEFICIENCY; HIGH RISK PATIENT; HUMAN; LEAN BODY WEIGHT; LIPID METABOLISM; MALABSORPTION; MALNUTRITION; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; FATTY ACIDS, UNSATURATED; FISH OILS; HUMANS; MALABSORPTION SYNDROMES; NUTRITIONAL STATUS; PHOSPHOLIPIDS;

EID: 18744403076     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510012136     Document Type: Article

References (29)

1. Decsi T, Zaknun D, Zaknun J, Sperl W, Koletzko B. Long-chain polyunsaturated fatty acids in children with severe protein-energy malnutrition without and with human immunodeficiency virus-1 infection. Am J Clin Nutr 1995;62:1283-8.
2. Decsi T, Molnar D, Koletzko B. The effect of under- and overnutrition on essential fatty acid metabolism in childhood. Eur J Clin Nutr 1998;52:541-8.
3. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W. Dietary supplementation with fish oil in ulcerative colitis. Annals Int Med 1992;116:609-14.
4. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60.
5. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone mineral density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Min Res 1995;10:250-6.
6. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. JPGN 1994;19:7-21.
7. Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365-3.
8. Esteve-Comas M, Nunez MC, Fernandes-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370-3.
9. Trebble TM, Wootton SA, May A, Erlewyn-Lajeunesse MD, Chakraborty A, Mullee MA, et al. Essential fatty acid status in pediatric Crohn's disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther 2003;18:433-42.
10. Hyams JS, Ferry GD, Mandel FS. Development and validation of pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
11. Hyams JS, Ferry GD, Mandel FS. Development and validation of pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 2003;18:433-42.
12. Trulove SC, Wins LJ. Cortisone in ulcerative colitis: final report on therapeutic trial. Br Med J 1955;2:1041-8.
13. Socha P, Koletzko B, Pawlowska P, Socha J. Essential fatty acid status in children with cholestasis, in relation to serum bilirubin concentration. J Pediatr 1997;131:700-6.
14. Cole TJ, Donnet ML, Stanfield JP. Weight-for-height indices to assess nutritional status: a new index on a slide-rule. Am J Clin Nutr 1981;34:1935-43.
15. Bhatia SJ, Moffitt SD, Goldsmith MA, Bain RP, Kutner MH, Rudman D. A method of screening for growth hormone deficiency using anthropometrics. Am J Clin Nutr 1981;34:281-8.
16. Kurniewicz-Witczakowa R. Rozwój fizyczny dzieci i młodziezy warszawskiej [Anthropometry of children and adolescents in Warsaw]. Warszawa: IMiD; 1983.
17. De Leenheer AP, De Bevere VORC, De Ruyter MGM, Claeys AE. Simultaneous determination of retinol and α-tocopherol in human serum by high-performance liquid chromatography. J Chromatogr 1979;162:408-13.
18. Koletzko B, Schmidt E, Bremer HJ, Haug M, Harzer G. Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr 1989;148:669-75.
19. Decsi T, Koletzko B. Fatty acid composition of plasma lipid classes in healthy subject from birth to young adulthood. Eur J Pediatr 1994;153:520-5.
20. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
21. Donovitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology 1985;88:580-7.
22. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 1988;95:11-7.
23. Wardle TD, Turnberg LA. Use of coculture of colonie mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 1992;33:1644-51.
24. Rampton DS, Sladen GE, Youlten LJ. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. Gut 1980;21:591-6.
25. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991;32:1151-5.
26. Middleton SJ, Naylor S, Woolner J, Hunter JO. A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 2002;16:1131-4.
27. Roberts WG, Simon TJ, Berlin RG, Haggitt RC, Snyder ES, Stenson WF, et al. Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 1997;112:725-32.
28. Hawkey CJ, Dube LM, Rountree LV, Linnen PJ, Lancaster JF. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group for ulcerative colitis. Gastroenterology 1997;112:718-24.
29. Lapillonne A, Carlson SE. Polyunsaturated fatty acids and infant growth. Lipids 2001;36:901-11.